Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia

References

• Chen J, Yu WM, Daino H, et al. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. Blood. 2007;109(2):778–785.
   PubMed Web of Science ®Google Scholar
• Troeger A, Glouchkova L, Ackermann B, et al. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95. Blood. 2008;112(4):1028–1034.
   PubMed Web of Science ®Google Scholar
• Passaro D, Irigoyen M, Catherinet C, et al. CXCR4 is required for leukemia-initiating cell activity in T cell acute lymphoblastic leukemia. Cancer Cell. 2015;27(6):769–779.
   PubMed Web of Science ®Google Scholar
• Domanska UM, Kruizinga RC, Nagengast WB, et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer. 2013;49(1):219–230.
   PubMed Web of Science ®Google Scholar
• Irving JA. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia. Br J Haematol. 2016;172(5):655–666.
   PubMed Web of Science ®Google Scholar
• Tovar CF, Zeron HM, Romero MD, et al. Glycogen synthase kinase-3β (GSK-3β) and nuclear factor kappa-B (NFKB) in childhood acute lymphoblastic leukemia. Adv Clin Exp Med. 2016;25(6):1139–1147.
   PubMed Web of Science ®Google Scholar
• Furqan M, Mukhi N, Lee B, et al. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark Res. 2013;1(1):5
   PubMedGoogle Scholar
• Baskiewicz-Masiuk M, Machalinski B. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. Eur J Haematol. 2004;72(6):420–429.
   PubMed Web of Science ®Google Scholar
• Ye TH, Yang FF, Zhu YX, et al. Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. Cell Death Dis. 2017;8(1):e2534
   PubMedGoogle Scholar
• Zhu Y, Ye T, Yu X, et al. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Sci Rep. 2016;6:20253.
   PubMed Web of Science ®Google Scholar
• Nishanth G, Deckert M, Wex K, et al. CYLD enhances severe listeriosis by impairing IL-6/STAT3-dependent fibrin production. PLoS Pathog. 2013;9(6):e1003455.
   PubMed Web of Science ®Google Scholar
• Wang X, Deckert M, Xuan NT, et al. Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol. 2013;126(5):711–724.
   PubMed Web of Science ®Google Scholar
• Xuan NT, Wang X, Nishanth G, et al. A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol. 2015;45(3):818–828.
   PubMed Web of Science ®Google Scholar
• Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature. 2009;459(7247):717–721.
   PubMed Web of Science ®Google Scholar
• Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712–716.
   PubMed Web of Science ®Google Scholar
• Xu Y, Hu J, Wang X, et al. Overexpression of MALT1-A20-NF-kappaB in adult B-cell acute lymphoblastic leukemia. Cancer Cell Int. 2015;15(1):73.
   PubMedGoogle Scholar
• Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350–2354.
   PubMed Web of Science ®Google Scholar
• Çalışkan C, Pehlivan M, Yüce Z, et al. Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines. Mol Biol Rep. 2017;44(5):391–397.
   PubMed Web of Science ®Google Scholar
• Wang JH, Wei W, Guo ZX, et al. Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma. J Transl Med. 2015;13:41.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wu J, Fu X, et al. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer. 2014;13:258.
   PubMed Web of Science ®Google Scholar
• Mulas F, Wang X, Song S, et al. The deubiquitinase OTUB1 augments NF-kappaB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13. Cell Mol Immunol. 2020;17(2):1–16.
   PubMed Web of Science ®Google Scholar
• Takemoto S, Mulloy JC, Cereseto A, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA. 1997;94(25):13897–13902.
   PubMed Web of Science ®Google Scholar
• Becker C, Fantini MC, Schramm C, et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 2004;21(4):491–501.
   PubMed Web of Science ®Google Scholar
• Arora L, Kumar AP, Arfuso F, et al. The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies. Cancers (Basel). 2018;10(9):327.
   PubMed Web of Science ®Google Scholar
• Schaper F, Rose-John S. Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 2015;26(5):475–487.
   PubMed Web of Science ®Google Scholar
• Weissenbach M, Clahsen T, Weber C, et al. Interleukin-6 is a direct mediator of T cell migration. Eur J Immunol. 2004;34(10):2895–2906.
   PubMed Web of Science ®Google Scholar
• Gubbels JA, Felder M, Horibata S, et al. MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells. Mol Cancer. 2010;9:11.
   PubMed Web of Science ®Google Scholar
• Birgen D, Ertem U, Duru F, et al. Serum Ca 125 levels in children with acute leukemia and lymphoma. Leuk Lymphoma. 2005;46(8):1177–1181.
   PubMed Web of Science ®Google Scholar
• Wu JZ, Tian T, Huang Y, et al. Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma. Cancer Biomark. 2016;17(2):205–212.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103(3):460–462.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;13(2):193–207.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Chen H, Hu L, Luo Z, et al. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Mol Cancer. 2015;14:186.
   PubMed Web of Science ®Google Scholar
• Hjelmeland AB, Wu Q, Wickman S, et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol. 2010;8(2):e1000319.
   PubMed Web of Science ®Google Scholar
• Wang M, Li S. Bladder polypoid cystitis-derived A20 associates with tumorigenesis. Cell Biochem Biophys. 2013;67(2):669–673.
   PubMed Web of Science ®Google Scholar
• Duy PN, Thuy NT, Trang BK, et al. Regulation of NF-κB- and STAT1-mediated plasmacytoid dendritic cell functions by A20. PLoS One. 2019;14(9):e0222697.
   PubMed Web of Science ®Google Scholar
• Hovelmeyer N, Reissig S, Xuan NT, et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol. 2011;41(3):595–601.
   PubMed Web of Science ®Google Scholar
• Silva CM. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene. 2004;23(48):8017–8023.
   PubMed Web of Science ®Google Scholar
• Weston VJ, Wei W, Stankovic T, et al. Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1. Exp Hematol. 2018;63:52–63 e5.
   PubMed Web of Science ®Google Scholar
• Luczyński W, Stasiak-Barmuta A, Iłendo E, et al. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol. 2006;53(2):377–382.
   PubMed Web of Science ®Google Scholar
• Salem ML, El-Shanshory MR, Abdou SH, et al. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia. Immunopharmacol Immunotoxicol. 2018;40(2):158–167.
   PubMed Web of Science ®Google Scholar
• Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 1992;71(7):1065–1068.
   PubMed Web of Science ®Google Scholar
• Tai YT, Podar K, Mitsiades N, et al. CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling. Blood. 2003;101(7):2762–2769.
   PubMed Web of Science ®Google Scholar
• Lee JH, Jung SM, Yang KM, et al. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1. Nat Cell Biol. 2017;19(10):1260–1273.
   PubMed Web of Science ®Google Scholar
• Xu L, Li J, Bao Z, et al. Silencing of OTUB1 inhibits migration of human glioma cells in vitro. Neuropathology. 2017;37(3):217–226.
   PubMed Web of Science ®Google Scholar
• Xuan NT, Trung DM, Minh NN, et al. Regulation of p38MAPK-mediated dendritic cell functions by the deubiquitylase otubain 1. Hla. 2019;93(6):462–470.
   PubMed Web of Science ®Google Scholar
• De Wilde K, Martens A, Lambrecht S, et al. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis. 2017;76(3):585–592.
   PubMed Web of Science ®Google Scholar
• Wooten DK, Xie X, Bartos D, et al. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J Biol Chem. 2000;275(34):26566–26575.
   PubMed Web of Science ®Google Scholar
• Badache A, Hynes NE. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res. 2001;61(1):383–391.
   PubMed Web of Science ®Google Scholar